Tibet AIM Pharm. Inc.
SHZ: 002826.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Zhou Min
- Employees
- 439
- Headquarters
- Beijing, China
- IPO year
- 2016
- Market cap
- CN¥3.6B
- Website
- https://www.emyy.cn
Loading 002826…
Loading profile data…Frequently asked questions about 002826
What does Tibet AIM Pharm. Inc. (002826.SZ) do?
Tibet AIM Pharm. Inc. engages in the research and development of medical products in China. The company's products include Miglitol tablets for diabetes; Gualoupi injection for coronary disease; Oxytocin injection for gynecology and obstetrics; NalMefene injection for various acute poisoning, such as alcohol, organic phosphor, CO, sedative-hypno...
Where does 002826.SZ trade?
Tibet AIM Pharm. Inc. (002826.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002826.SZ in?
Tibet AIM Pharm. Inc. (002826.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Tibet AIM Pharm. Inc.?
Zhou Min is the chief executive officer of Tibet AIM Pharm. Inc. (002826.SZ).
Where is Tibet AIM Pharm. Inc. headquartered?
Tibet AIM Pharm. Inc. is headquartered in China.
Does 002826.SZ pay a dividend?
Yes — Tibet AIM Pharm. Inc. (002826.SZ) paid a trailing twelve-month dividend of CNY 0.10 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002826.SZ go public?
Tibet AIM Pharm. Inc. (002826.SZ) completed its initial public offering in 2016.